BRIEF-ORIC Pharmaceuticals Q1 Net Income USD -30.021 Million

Reuters
May 06
BRIEF-ORIC Pharmaceuticals Q1 Net Income USD -30.021 Million

May 05 (Reuters) - ORIC Pharmaceuticals Q1 basic EPS USD -0.42 vs. IBES estimate USD -0.51.

  • Q1 income from operations USD -32.718 million
  • Q1 operating expenses USD 32.718 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10